类风湿关节炎缓解率提升但持续缓解未改善且复发率升高:1990至2019年人群队列研究
该研究基于美国Olmsted County 1990至2019年新发类风湿关节炎(RA)人群队列,随访至2023年底。结果显示1年缓解率从12.8%升至26.4%,中位缓解时间从6.4年缩短至2.8年,但缓解后5年内复发率从62.8%升至79.2%,持续缓解未见改善。
要点
- 1年缓解率从12.8%升至26.4%,中位缓解时间从6.4年缩短至2.8年
- 缓解后5年内复发率从62.8%升至79.2%,持续缓解未改善
- 持续缓解仍是RA治疗的关键未满足需求
核心结论
- RA缓解随时间更早、更频繁,但缓解持久性未改善,复发率升高。
研究设计与样本
- 基于美国明尼苏达州Olmsted County的人群首发队列,纳入1990至2019年符合1987或2010 ACR标准的成人新发RA患者,随访至2023年12月31日。
主要发现
- 共1179例患者,中位随访9.4年,816例达到缓解,630例达到持续缓解。
- 1年缓解率从1990–1999年的12.8%升至2010–2019年的26.4%。
- 中位缓解时间从6.4年缩短至2.8年。
- 缓解后5年内复发率从1990–1999年的62.8%升至2010–2023年的79.2%。
关键数值与推荐
- 持续缓解定义为缓解持续≥6个月。
- 采用竞争风险模型估计首次缓解、持续缓解及缓解后复发的累积发生率。
- Cox模型比较日历时期,校正年龄、性别、基线体重指数和血清学状态。
临床怎么用
- 临床应关注RA缓解后的复发风险,加强持续缓解策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report population-level data describing long-term trends in remission, sustained remission and relapse among patients with rheumatoid arthritis (RA). METHODS: We conducted a population-based inception cohort study of adults with incident RA in Olmsted County, Minnesota, USA, meeting 1987 or 2010 ACR criteria between 1990 and 2019. Patients were followed through 31 December 2023. We estimated cumulative incidence of first remission, sustained remission (≥6 months) and relapse after remission, accounting for competing risk of death. Cox models comparing calendar periods were adjusted for age, sex, baseline body mass index and serostatus. RESULTS: Among 1179 patients followed for a median of 9.4 years, 816 achieved remission and 630 achieved sustained remission. One-year remission, defined by our prespecified criteria, increased from 12.8% in 1990–1999 to 26.4% in 2010–2019. Median time to remission shortened from 6.4 years to 2.8 years. Despite these gains, relapse within 5 years after remission increased from 62.8% in 1990–1999 vs 79.2% in the 2010–2023 period. CONCLUSION: Remission in RA has become earlier and more frequent over time, but durability has not improved. Strategies to sustain remission remain a critical unmet need.
引用
- El Hasbani G, Jose George R, J Achenbach S, et al. Transformative improvement with staggered gains in rheumatoid arthritis remission and sustained remission, but higher relapse rates: a population-based cohort study from 1990 to 2019. RMD Open. 2026. PMID: 42919621. doi:10.1136/rmdopen-2026-007297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。